US Stock MarketDetailed Quotes
VBIV VBI Vaccines
- 0.590
- -0.019-3.04%
Close Apr 24 16:00 ET
- 0.590
- +0.000+0.02%
Pre 08:00 ET
16.78MMarket Cap-97P/E (TTM)
0.610High0.580Low130.14KVolume0.594Open0.609Pre Close77.35KTurnover0.49%Turnover RatioLossP/E (Static)28.43MShares3.47052wk High2.23P/B15.67MFloat Cap0.45052wk Low--Dividend TTM26.56MShs Float2360.907Historical High--Div YieldTTM4.90%Amplitude0.095Historical Low0.594Avg Price1Lot Size
About VBI Vaccines Company
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Company Profile
SymbolVBIV
Company NameVBI Vaccines
Listing DateMay 9, 2016
Founded1965
CEOMr. Jeffrey R. Baxter
MarketNASDAQ
Employees138
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address160 2nd Street,Floor 3
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-830-3031
Websitehttp://www.vbivaccines.com
Company Executives
- Name
- Position
- Salary
- Jeffrey R. Baxter
- Director, President and Chief Executive Officer
- 1.83M
- Nell Beattie
- Director, Principal Accounting Officer, Chief Financial Officer and Head of Corporate Development
- --
- Dr. David E. Anderson, PhD
- Chief Scientific Officer
- 995.44K
- Dr. Francisco Diaz-Mitoma
- Chief Medical Officer
- 1.01M
- John Robert Dillman
- Chief Commercial Officer
- --
- Avi Mazaltov
- Global Head of Manufacturing and SciVac General Manager
- --
- Dr. Steven Gillis, Pd.D
- Chairman of the Board
- 102.50K
- Dr. Vaughn B. Himes,PhD
- Director
- --
- Dr. Michel De Wilde
- Independent Director
- 47.50K
- Joanne Cordeiro
- Independent Director
- 62.50K
- Damian Braga
- Independent Director
- 55.05K
- Blaine McKee
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg